Knowstox

Fundamentals snapshot

Accelerant Holdings

ARX · NYQ · Financial Services · Insurance Brokers

Current price

$19.77

52-week range

$9.18 - $19.90

Market cap

$4.29B

One-glance verdict

Valued differently

We value banks a different way

We don't put a cash-flow fair value on banks and insurers. For these companies the reported 'cash flow' is really just money moving between loans, deposits and trades — not the leftover profit the owners could actually pocket — so the usual method would print a misleading number.

Balance sheet

Healthy

-18.16x Concerning

Net cash $1.54B. Interest coverage shows how many times profit covers the interest bill.

What this company does

Accelerant Holdings

Accelerant Holdings acts as a middleman for specialized insurance, connecting insurance writers with investors who provide the money to cover potential claims. The company makes its money primarily from fees charged to these investors for bringing them business and managing it on its technology platform. This matters because it shows how Accelerant facilitates insurance coverage for businesses by efficiently linking those who want to insure with those who fund it, all through a digital exchange.

Price history

How the share price has moved

—
Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Revenue $356.90M
Net income —
Diluted EPS 0.36
Operating cash flow $-68.60M
Free cash flow —
Revenue $273.30M
Net income —
Diluted EPS -0.02
Operating cash flow $-21.40M
Free cash flow —
Revenue $248.40M
Net income —
Diluted EPS -0.57
Operating cash flow $61.90M
Free cash flow —
Revenue $267.40M
Net income $-1.37B
Diluted EPS -6.99
Operating cash flow $73.90M
Free cash flow —
Revenue $219.10M
Net income $8.80M
Diluted EPS 0.04
Operating cash flow $217.50M
Free cash flow —
Revenue $178.00M
Net income —
Diluted EPS 0.03
Operating cash flow $91.80M
Free cash flow —
Revenue $602.60M
Net income —
Diluted EPS 0.14
Operating cash flow $241.80M
Free cash flow —
Revenue $153.70M
Net income $8.10M
Diluted EPS 0.04
Operating cash flow $276.40M
Free cash flow —

Is it cheap or expensive?

We value banks and insurers a different way

For a bank or insurer, the "free cash flow" shown on its statements is mostly money flowing through loans, deposits and trades — not the leftover profit the owners could actually keep, which is what this kind of valuation needs. Running that through the usual method would spit out a meaningless number, so we leave the cash-flow fair value out here rather than show you something misleading.

Valued differently

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Is it drowning in debt?

Healthy

Net cash $1.5B - more cash than debt. Interest coverage -18.2x.

Net debt $-1.54B
Interest coverage -18.16x

Accelerant Holdings's profit covers its interest bill about 0.0 times over. which is weaker than most peers shown here.

Healthy
Worse cushion Baseline Better cushion
ARX BASELINE Accelerant Holdings

Total debt $120.10M Interest coverage -18.16x This is the baseline the peer rows are being compared against.

Total debt $3.81B Interest coverage 2.32x This peer still has a real interest-payment cushion, while ARX does not.

Total debt $224.54M Interest coverage 60.58x This peer still has a real interest-payment cushion, while ARX does not.

Total debt $8.07B Interest coverage 4.91x This peer still has a real interest-payment cushion, while ARX does not.

Total debt $372.84M Interest coverage 3.14x This peer still has a real interest-payment cushion, while ARX does not.

What you should know

The case for and against ARX

2 Rewards 1 Risk

Rewards

  • Revenue grew 25.5% last year.
  • Free cash flow was positive in 4/10 years.

Risks

  • Return on equity was -222.0% last year — the company lost money on shareholders' equity.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
—
Forward P/E
21.11x
P/B
5.98x
P/S
4.01x
EV/EBITDA
25.41x
PEG ratio
—

Profitability

How much profit each dollar creates

Gross margin
65.1%
Operating margin
15.6%
Net margin
-127.5%
ROE
-222.0%
ROA
0.5%

Health

Liquidity and balance-sheet strength

Debt / equity
0.16x
Current ratio
11.33x
Quick ratio
11.06x
Total debt
$120.10M
Total cash
$1.66B

Growth

How the business has been compounding

Revenue TTM
$1.15B
Revenue 5Y CAGR
165.4%
EPS TTM
-6.22
EPS 5Y CAGR
—

Cash flow

How much cash the business throws off

Operating CF TTM
$45.80M
Free CF TTM
$403.70M
FCF margin
35.2%

Dividend

Shareholder payout

Yield
0.0%
Payout ratio
0.0%
Last ex-div date
—